๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Chengdu
Clinical trial register · China

Clinical Trials in Chengdu, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Chengdu 15 Guiyang 2 Hefei 2 Nanning 2 รœrรผmqi 2
Narrow the registerReset
Recruitment status
Phase
Site location
Chengdu15 Guiyang2 Hefei2 Nanning2 รœrรผmqi2
All 10 locations
Target enrolment
to

Trials with a site in Chengdu

15 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Luvometinib in Pediatric SS-LCH With Special-site Single/Multifocal Bone Lesions
NCT07371182Langerhans Cell Histiocytosis (LCH)
West China Second University Hospital
Not applicable
62
Hefei, Nanning, Guiyang, Zunyi, Nanchang, Xi'an, Chengdu, รœrรผmqi
2026-06-19
Not yet open
A Multicenter Cohort Study of Duchenne and Becker Muscular Dystrophy in Western Chinese Children
NCT07511920Muscular Dystrophy, Becker, Muscular Dystrophy, Muscular Dystrophy (DMD), Muscular Dystrophy, Duchenne
West China Second University Hospital
Observational
500
Chengdu
2026-04-20
Recruiting
Modified LCH-III Regimen With or Without Luvometinib for Multisystem Pediatric Langerhans Cell Histiocytosis
NCT07431060Langerhans Cell Histiocytosis (LCH)
West China Second University Hospital
Not applicable
120
Chengdu, Guiyang, Hefei, Jiangxi, Kunming, Nanning, รœrรผmqi, Xi'an
2026-02-13
Not yet open
Exploring Gut Microbiome Differences in Female Cancer Patients With Varied Ovarian Function and Fertility Outcomes Following Immune Checkpoint Inhibitor Therapy
NCT07201259Malignant Tumors
West China Second University Hospital
Observational
40
Chengdu
2025-10-10
Not yet open
Comparing the Efficacy of TU-LESS and vNOTES for Hysterectomy of Enlarged Uterus
NCT06663553Enlarged Uterus, Adenomyosis, Uterine Fibroids (UF)
West China Second University Hospital
Not applicable
210
Chengdu
2025-10-01
Recruiting
Real-world Study of Darafenib or Trametinib and Clofarabine for High-risk/Recurrent/Refractory Langerhans Cell Histiocytosis in Children
NCT07022834Langerhans Cell Histiocytosis (LCH)
West China Second University Hospital
Phase 2
20
Chengdu
2025-06-01
By invitation
A Integrated Study in Pediatric Patients with Cardiomyopathy
NCT06641830Pediatric Cardiomyopathy
West China Second University Hospital
Observational
800
Chengdu
2024-09-01
By invitation
Magnetic Resonance Myocardial Stress Perfusion in Pediatric Patients with Cardiovascular Disease
NCT06641843Kawasaki Disease, Cardiovascular Disease, Anomalous Origin of Coronary Artery
West China Second University Hospital
Observational
240
Chengdu
2024-09-01
Recruiting
Peginterferon ฮฑ-2b Injection for Aerosol Therapy in Pediatric Respiratory Syncytial Virus Pneumonia
NCT06881056Respiratory Syncytial Virus (RSV)
West China Second University Hospital
Not applicable
90
Chengdu
2024-07-17
Recruiting
A Study of Concurrent Chemoradiotherapy Followed by Cadonilimab๏ผˆAK104๏ผ‰ for Newly Diagnosed Local Advanced Cervical Cancer
NCT06251388Cervical Cancer
West China Second University Hospital
Phase 2
50
Chengdu
2024-02-20
Recruiting
Cardiac Magnetic Resonance Monitoring of Immune Checkpoint Inhibitor-related Cardiotoxicity
NCT06132984Immune Checkpoint Inhibitors, Cardiotoxicity
West China Second University Hospital
Observational
22
Chengdu
2023-11-23
By invitation
Cardiovascular Imaging in Pediatric Myocarditis
NCT06652399Myocarditis
West China Second University Hospital
Observational
100
Chengdu
2023-11-01
By invitation
The Value of Cardiovascular Imaging in Kawasaki Disease
NCT06641817Kawasaki Disease
West China Second University Hospital
Observational
500
Chengdu
2023-09-01
Active, closed
Comparison Between Laparoendoscopic Single-site Surgery and Multi-port Laparoscopy in Treating Uterine Fibroids
NCT06244251Uterine Fibroid, Uterine Sarcoma, Uterine Leiomyosarcoma
West China Second University Hospital
Not applicable
5,000
Chengdu
2023-06-24
Recruiting
Value of LNG-IUS as Fertility-preserving Treatment of EAH and EC
NCT03463252Endometrial Cancer, Atypical Endometrial Hyperplasia
DrugGnRH-a
West China Second University Hospital
Phase 2/3
224
Chengdu
2018-04-01
Rows per page Showing 1–15 of 15
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 26 September 2026. https://priyalifescience.com/clinical-trials-china/city/chengdu

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 15 of those studies with a site in Chengdu that also match the filters currently applied.

How many clinical trials are recruiting in Chengdu?

7 of the 15 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 3 have not yet opened recruitment, 1 are active but closed to new participants, and 4 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Chengdu), 15 studies
PhaseStudiesRecruitingShare
Observational7146.7%
Not applicable5333.3%
Phase 22213.3%
Phase 2/3116.7%

Most active sponsors

Lead sponsors with the most studies (Chengdu)
Lead sponsorStudiesRecruiting
West China Second University Hospital157
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.